Compositions and methods for the treatment of HER2-expressing solid tumors

Recombinant adenoviruses expressing the extracellular (EC) and transmembrane (TM) domains of human HER2 (HER2ECTM) are described. The recombinant adenoviruses express a chimeric fiber protein having the adenovirus type 35 (Ad5) shaft and knob domains, which facilitates transduction of human dendritic cells by the recombinant HER2ECTM expressing adenovirus. Compositions that include dendritic cells transduced by the recombinant adenovirus and their use for treating HER-positive tumors is described..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 13. Apr. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

WOOD LAUREN V [VerfasserIn]
ROBERSON BRENDA D [VerfasserIn]
BERZOFSKY JAY A [VerfasserIn]
MORRIS JOHN C [VerfasserIn]
STEEL JASON C [VerfasserIn]
TERABE MASAKI [VerfasserIn]
BRENNER MALCOLM K [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-04-13, Last update posted on www.tib.eu: 2023-11-13, Last updated: 2023-11-17

Patentnummer:

AU2016343845

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA006128831